MAPT and amyloidosis: The 3xTg-AD model combines mutations in APP, PS1, and tau, exhibiting both amyloidosis and tauopathy, though it does not fully replicate human AD neurodegeneration or microglial/inflammatory responses (Oddo et al., 2003).